ELISA/Act Biotechnologies, LLC
Lymphocyte Response Assay (LRA) by ELISA/ACT® tests provide patient-specific information about all delayed hypersensitivity (DTH) / delayed allergy pathways. The patented LRA by ELISA/ACT tests were developed in 1984, enabling thousands of physicians to quickly and precisely determine the hidden causes of many chronic conditions and help their patients find sustained relief.
